CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound.
​Â
​CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data for its lead compound.
read moreÂ